Biotechnology Medical Devices Medical Specialties News Pharma & Biotechnology Press

Nuclear Medicine/Radiopharmaceuticals Market Booming US$ 6,683.99 Mn by 2027 Worldwide with Bayer AG, Positron Corporation, NTP Radioisotopes SOC Ltd., Bracco, Lantheus Medical Imaging Inc., Advanced Accelerator Applications

The global nuclear medicine/radiopharmaceuticals market expected to be US$ 3,982.11 Mn in 2018 and is predicted to grow at a CAGR of 6.2% during the forecast period 2019 – 2027, to reach US$ 6,683.99 Mn by 2027.

The chronic diseases such as heart diseases, cancer, chronic lung diseases, stroke, Alzheimer’s disease, and chronic kidney disease and other neurological disorders are growing at a rapid rate across the globe. These chronic diseases are the leading cause of deaths. According to the recent statistics of World Health Organization for the year 2019, states that chronic disease contributes approximately 60% of all deaths and 43% of the global burden of disease. It is also expected that by 2020 the incidences of deaths will rise approximately to 73% and the global burden of disease is expected to grow by 60%.

These chronic diseases need to be examined before the further treatment starts. And the nuclear medicines are used for the diagnosis and examination purposes. Nuclear medicines in PET and SPECT are used for the therapeutic and diagnostic purposes. Thus, owing to the increasing incidences of chronic diseases poses several opportunities for the nuclear medicine/radiopharmaceuticals market to grow during the forecast period.

The Insight Partners has added an innovative data titled as Nuclear Medicine/Radiopharmaceuticals Market. Different perspectives are examined by using primary as well as secondary research techniques. It includes a detailed overview of different trends, in terms of geographic, economic, social, cultural and much more. The market is presented to the readers as a snapshot of the global sectors. The comparative analysis of global and regional players are presented in the report of business domain. Different parameters such as prices, shares, revenue, are evaluated to determine the financial strategies of the businesses. The as Nuclear Medicine/Radiopharmaceuticals market is expected to reach at 2019 in the forecast period of 2026.

Request for Buy Report @

https://www.theinsightpartners.com/buy/TIPRE00003751/

Top Leading Vendors of Nuclear Medicine/Radiopharmaceuticals Market :-

Cardinal Health

IBA Worldwide

Curium

GENERAL ELECTRIC

Bayer AG

Positron Corporation

NTP Radioisotopes SOC Ltd.

Bracco

Lantheus Medical Imaging Inc.

Advanced Accelerator Applications

The top driving factors and opportunities are scrutinized, along with the restraints, which are beneficial for balancing the ups and downs within the business methodology. The study throws light on Nuclear Medicine/Radiopharmaceuticals market, and mainly focusing on growth factors.  Application, types, and technologies are studied to decide the platform of the businesses.

NUCLEAR MEDICINE/RADIOPHARMACEUTICALS – MARKET SEGMENTATION 

By Application

  • Diagnostic Applications
    • SPECT (Single-Photon Emission Computed Tomography) Applications
    • PET (Positron Emission Tomography) Applications
  • Therapeutic Applications
    • Thyroid
    • Bone Metastasis
    • Lymphoma
    • Endocrine Tumors
    • Other Therapeutic Applications 

By End User

  • Hospitals
  • Diagnostic Centers

The competitive landscape of the Nuclear Medicine/Radiopharmaceuticals market, focuses on competitors at global as well as domestic level.

Get a sample Copy of this report now! @

https://www.theinsightpartners.com/sample/TIPRE00003751/

Reasons to BUY this Report:

  • Identified current and future development of the Global Nuclear Medicine/Radiopharmaceuticals Market.
  • Competitive Event management mapping the key public trends.
  • Make available market size to assist with planning and strategic decisions.
  • A five years forecast of the market.
  • Detailed research and segmentation for the market.
  • Helps you to understand market dynamics to give you deeper understanding of the market.
  • To reveal opportunities for Nuclear Medicine/Radiopharmaceuticals Market.
  • Strategic references for the new competitors.

Additionally, Nuclear Medicine/Radiopharmaceuticals market comprises of various vendors and suppliers across the globe. Different attributes are studied and presented such as, the company profiles, specification of services and products that are offered by the industries. A complete SWOT and Porter’s five analysis, are used while scrutinizing the facts.

Table of Content:-

Chapter 1 Global Nuclear Medicine/Radiopharmaceuticals Market Overview

Chapter 2 Market Data Analysis

Chapter 3 Market Technical Data Analysis

Chapter 4 Market Government Policy and News

Chapter 5 Market Demand 2019-2026

Chapter 6 Market Status and Forecast 2019-2026

Chapter 7 Global Nuclear Medicine/Radiopharmaceuticals Market Key Vendors

Chapter 8 Up and Down Stream Industry Analysis

Chapter 9 Marketing Strategy – Market Analysis

Chapter 10 Market Development Trend Analysis

Chapter 11 Global Nuclear Medicine/Radiopharmaceuticals Market New Project Investment Feasibility Analysis

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com

Prashant Tambe
Prashant Tambe
An expert in SEO, Prashant carries an experience of over five years in the industry. He has the ability to analyze global industry trends that helps the leaders to make smarter decisions. An electrical, electronics and communication engineer, Prashant is able to predict future trends as they are changing fast with technological development.